Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPension (IS)Preferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bruker (BRKR) Revenue (2016 - 2026)

Bruker filings provide 16 years of Revenue readings, the most recent being $977.2 million for Q4 2025.

  • On a quarterly basis, Revenue changed 0.24% to $977.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.4 billion, a 2.08% increase, with the full-year FY2025 number at $3.4 billion, up 2.08% from a year prior.
  • Revenue hit $977.2 million in Q4 2025 for Bruker, up from $860.5 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $979.6 million in Q4 2024 to a low of $554.7 million in Q1 2021.
  • Median Revenue over the past 5 years was $715.0 million (2022), compared with a mean of $735.8 million.
  • Biggest five-year swings in Revenue: soared 34.43% in 2021 and later dropped 0.45% in 2025.
  • Bruker's Revenue stood at $683.5 million in 2021, then rose by 3.64% to $708.4 million in 2022, then rose by 20.62% to $854.5 million in 2023, then grew by 14.64% to $979.6 million in 2024, then decreased by 0.24% to $977.2 million in 2025.
  • The last three reported values for Revenue were $977.2 million (Q4 2025), $860.5 million (Q3 2025), and $797.4 million (Q2 2025) per Business Quant data.